临床试验/JPRN-UMIN000047156

JPRN-UMIN000047156招募中未知

Randomized comparative study of third-generation Narrow band imaging (NBI) and White light imaging (WLI) in the diagnosis of the presence of early gastric cancer. - Detection of early gastric cancer by 3rd generation NBI

ara Medical University0 个研究点目标入组 566 人开始时间: 2022年4月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 招募中
发起方
入组人数: 566

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•Post gastrectomy Endoscopic treatment non curative resection

研究者

发起方

ara Medical University

相似试验

A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400 mg daily versus imatinib 800 mg daily versus imatinib plus PEG interferon-alpha 2a (Pegasys) in patients with newly-diagnosed chronic phasechronic myeloid leukaemiaChronic Myeloid LeukaemiaCancer

ISRCTN59346371ewcastle upon Tyne Hospitals Trust (UK)2,466

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B37 CandidiasisB37Candidiasis

PER-023-04FUJISAWA HEALTH CARE INC,

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCandidiasis-B37 CandidiasisB37

PER-026-04FUJISAWA HEALTH CARE INC,

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379

PER-024-04FUJISAWA HEALTH CARE INC,

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379

PER-046-04FUJISAWA HEALTH CARE INC,